Xinhua News Agency, Geneva, October 11 (Reporter Liu Qu) Experts from the World Health Organization suggested on the 11th that for all the new crown vaccines that have passed the WHO emergency use certification, people with moderate and severe immune insufficiency should receive an additional dose of booster Needle
The WHO Strategic Advisory Group of Immunization Experts believes that the above-mentioned immunocompromised population is “unlikely to respond adequately to vaccination after the standard basic vaccination plan, and faces a high risk of severe COVID-19”
At present, the new crown vaccines that have been certified for emergency use by WHO include: vaccines jointly developed by Pfizer Pharmaceuticals Co.
The WHO has also recently launched a global new crown vaccination strategy to achieve the goal of vaccinating about 40% of the population of all countries with the new crown vaccine by the end of 2021 and increasing the proportion of the population vaccinated to 70% by the middle of 2022
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
